Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 25, showing 5 Applications out of 121 total, starting on record 41, ending on 45

# Protocol No Study Title Investigator(s) & Site(s)

41.

ECCT/23/10/07   Fermented Food and Prediabetes
        A Study of the Hypoglycemic Effect of African Traditonal Fermented Foods amongst Prediabetic Adults.   
Principal Investigator(s)
1. Rosebella Iseme - Ondiek
Site(s) in Kenya
1. Aga Khan Outreach Centre Nairobi CBD/Town (Nairobi City county)
2. Aga Khan Outreach Centre Valley Arcade (Nairobi City county)
3. Aga Khan Outreach Centre Capital Centre (Nairobi City county)
4. Aga Khan Outreach Centre Kiambu Town (Kiambu county)
5. Aga Khan Outreach Centre Juja (Kiambu county)
6. Aga Khan Outreach Centre Ruiru (Kiambu county)
7. Aga Khan Outreach Centre Ongata Rongai (Kajiado county)
8. Aga Khan Outreach Centre Ngong (Kajiado county)
9. Aga Khan Outreach Centre Kitengela (Kajiado county)
 
View

42.

ECCT/13/01/01  
        An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination with Flucytosine as Compared to Fluconazole Alone   
Principal Investigator(s)
1. Ana-Claire Meyer
2. Judith Kwasa
3. Mark Jacobson
Site(s) in Kenya
1. Family AIDS Care and Education Services, Lumumba Health Center (Kisumu county)
2. Family AIDS Care and Education Services, Suba District Hospital (Homa Bay county)
 
View

43.

ECCT/11/08/05   Rifapentine During Intensive Phase TB Treatment
        Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis   
Principal Investigator(s)
1. Lena Matata
2. Kevin Cain
Site(s) in Kenya
KEMRI/CDC-KISUMU
 
View

44.

ECCT/21/02/04   GASTROSAM
     GASTROSAM   Gastroenteritis: Rehydration of children with severe acute malnutrition   
Principal Investigator(s)
1. Professor Kathryn Maitland
Site(s) in Kenya
Kilifi County Hospital
 
View

45.

ECCT/18/04/01   CKAF156 STUDY
    A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. KEMRI CDC (Siaya county)
2. Walter Reed Project (Kisumu county)
 
View